This included positive HER2 status, larger tumor sizes, distant metastasis and advanced clinical stage, indicating ZNF132 suppresses the progression of BC by inhibiting the growth, invasion, and metastasis of tumor cells. Here, ERBB2 is linked to breast cancer.